MGO One Seven LLC Buys 411 Shares of Corteva, Inc. (NYSE:CTVA)

MGO One Seven LLC lifted its stake in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 5.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,641 shares of the company’s stock after acquiring an additional 411 shares during the period. MGO One Seven LLC’s holdings in Corteva were worth $435,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Flagship Wealth Advisors LLC bought a new stake in shares of Corteva during the fourth quarter worth $25,000. Noble Wealth Management PBC bought a new stake in shares of Corteva during the fourth quarter worth $26,000. Hager Investment Management Services LLC bought a new stake in shares of Corteva during the fourth quarter worth $27,000. Golden State Wealth Management LLC bought a new stake in shares of Corteva during the fourth quarter worth $32,000. Finally, Centricity Wealth Management LLC bought a new stake in shares of Corteva during the fourth quarter worth $34,000. Institutional investors own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on CTVA shares. KeyCorp raised their target price on shares of Corteva from $70.00 to $71.00 and gave the company an “overweight” rating in a research report on Monday, April 14th. Citigroup raised their target price on shares of Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. Royal Bank of Canada raised their target price on shares of Corteva from $72.00 to $73.00 and gave the company an “outperform” rating in a research report on Friday, February 7th. Bank of America raised their target price on shares of Corteva from $69.00 to $73.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Finally, Wells Fargo & Company raised their target price on shares of Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $68.13.

Check Out Our Latest Analysis on CTVA

Insider Transactions at Corteva

In related news, insider Brian Titus sold 26,560 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the sale, the insider now owns 11,347 shares of the company’s stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.14% of the stock is owned by corporate insiders.

Corteva Price Performance

Shares of NYSE CTVA opened at $61.50 on Monday. The firm has a market cap of $42.01 billion, a P/E ratio of 47.67, a price-to-earnings-growth ratio of 1.68 and a beta of 0.73. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. Corteva, Inc. has a 1-year low of $50.01 and a 1-year high of $66.24. The business’s 50 day moving average is $60.71 and its 200-day moving average is $60.44.

Corteva (NYSE:CTVAGet Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. Equities research analysts predict that Corteva, Inc. will post 2.96 earnings per share for the current year.

About Corteva

(Free Report)

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

Read More

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.